• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药物相关性颌骨坏死患者保守治疗中临床症状和 CT 表现加重的因素:53 例多中心回顾性研究。

Factors Exacerbating Clinical Symptoms and CT Findings in Patients with Medication-Related Osteonecrosis of the Jaw Receiving Conservative Therapy: A Multicenter Retrospective Study of 53 Cases.

机构信息

Department of Dentistry and Oral Surgery, Kansai Medical University, Hirakata 573-1191, Japan.

Department of Oral Health, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852-8588, Japan.

出版信息

Int J Environ Res Public Health. 2022 Jun 26;19(13):7854. doi: 10.3390/ijerph19137854.

DOI:10.3390/ijerph19137854
PMID:35805513
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9265462/
Abstract

Recent reports have shown that better treatment outcomes are obtained with surgical therapy in patients with medication-related osteonecrosis of the jaw (MRONJ) than with conservative therapy. However, conservative treatment is selected due to factors such as old age and poor general condition. Conservative therapy aims to relieve symptoms and prevent lesion exacerbation; however, the lesion may expand rapidly in some cases. This study investigated the clinical and imaging findings of 53 MRONJ patients undergoing conservative therapy, and the changes in the clinical findings and the lesion enlargement on CT imaging were examined. Improved clinical findings and no worsening of the imaging findings were considered overall comprehensive treatment successes. Among the 53 patients, the clinical symptoms disappeared or improved in 15 patients, whereas they worsened in 6. In contrast, osteolytic lesion enlargement occurred in 17 patients. The comprehensive treatment outcome of conservative therapy was successful in 12 patients and unsuccessful in 41 patients. The periosteal reaction was significantly correlated with poor comprehensive treatment outcomes ( = 0.038). MRONJ lesions may advance, even if they appear to improve clinically while undergoing conservative treatments. Patients, especially those with periosteal reactions, must be closely followed up with CT examinations, regardless of the clinical findings.

摘要

最近的报告表明,对于药物相关性颌骨骨坏死(MRONJ)患者,手术治疗的疗效优于保守治疗。但是,由于年龄较大和一般状况较差等因素,选择了保守治疗。保守治疗旨在缓解症状和防止病变恶化;然而,在某些情况下,病变可能会迅速扩大。本研究调查了 53 例接受保守治疗的 MRONJ 患者的临床和影像学发现,并检查了临床发现的变化和 CT 影像学上的病变扩大情况。如果临床发现改善且影像学发现无恶化,则认为是整体综合治疗成功。在 53 例患者中,15 例患者的临床症状消失或改善,而 6 例患者的症状恶化。相比之下,17 例患者出现溶骨性病变扩大。保守治疗的综合治疗成功率为 12 例,失败率为 41 例。骨膜反应与较差的综合治疗结果显著相关(=0.038)。即使在接受保守治疗时临床症状似乎有所改善,MRONJ 病变也可能会进展。无论临床发现如何,患者,尤其是有骨膜反应的患者,必须密切随访 CT 检查。

相似文献

1
Factors Exacerbating Clinical Symptoms and CT Findings in Patients with Medication-Related Osteonecrosis of the Jaw Receiving Conservative Therapy: A Multicenter Retrospective Study of 53 Cases.药物相关性颌骨坏死患者保守治疗中临床症状和 CT 表现加重的因素:53 例多中心回顾性研究。
Int J Environ Res Public Health. 2022 Jun 26;19(13):7854. doi: 10.3390/ijerph19137854.
2
Periosteal reaction of medication-related osteonecrosis of the jaw (MRONJ): clinical significance and changes during conservative therapy.药物相关性颌骨骨髓炎(MRONJ)的骨膜反应:临床意义及保守治疗中的变化。
Support Care Cancer. 2021 Nov;29(11):6361-6368. doi: 10.1007/s00520-021-06214-9. Epub 2021 Apr 21.
3
Is the conservative non-surgical management of medication-related osteonecrosis of the jaw an appropriate treatment option for early stages? A long-term single-center cohort study.药物相关性颌骨骨坏死的保守非手术治疗是否适用于早期阶段?一项长期的单中心队列研究。
J Craniomaxillofac Surg. 2019 Mar;47(3):491-499. doi: 10.1016/j.jcms.2018.12.014. Epub 2018 Dec 29.
4
Imaging findings and treatment outcomes of a rare subtype of medication-related osteonecrosis of the jaw.一种罕见亚型的药物相关性颌骨骨坏死的影像学表现和治疗结果。
J Bone Miner Metab. 2022 Jan;40(1):150-156. doi: 10.1007/s00774-021-01267-6. Epub 2021 Sep 12.
5
Risk factors associated with prognosis of patients with medication-related osteonecrosis of the jaw.与药物相关性颌骨坏死患者预后相关的危险因素。
Head Neck. 2024 Feb;46(2):282-290. doi: 10.1002/hed.27574. Epub 2023 Nov 14.
6
Clinical significance of periosteal reaction as a predictive factor for treatment outcome of medication-related osteonecrosis of the jaw.骨膜反应作为预测药物相关性颌骨骨坏死治疗效果的一个因素的临床意义。
J Bone Miner Metab. 2019 Sep;37(5):913-919. doi: 10.1007/s00774-019-00994-1. Epub 2019 Mar 4.
7
CT imaging features of antiresorptive agent-related osteonecrosis of the jaw/medication-related osteonecrosis of the jaw.抗吸收剂相关性颌骨坏死/药物相关性颌骨坏死的 CT 影像学特征。
Dentomaxillofac Radiol. 2018 May;47(4):20170323. doi: 10.1259/dmfr.20170323. Epub 2018 Feb 13.
8
How does the clinical and tomographic appearance of MRONJ influences its treatment prognosis?MRONJ 的临床和影像学表现如何影响其治疗预后?
Dentomaxillofac Radiol. 2023 Nov;52(8):20230304. doi: 10.1259/dmfr.20230304. Epub 2023 Oct 23.
9
Medication-related osteonecrosis of the jaw in oncological patients with skeletal metastases: conservative treatment is effective up to stage 2.患有骨骼转移的肿瘤患者颌骨药物相关性骨坏死:保守治疗在2期之前有效。
Br J Oral Maxillofac Surg. 2017 Oct;55(8):787-792. doi: 10.1016/j.bjoms.2017.06.014. Epub 2017 Jul 29.
10
Conservative surgical treatment of medication related osteonecrosis of the jaw (MRONJ) lesions in patients affected by osteoporosis exposed to oral bisphosphonates: 24 months follow-up.骨质疏松症患者接受口服双膦酸盐治疗后发生药物相关性颌骨骨坏死(MRONJ)病变的保守性外科治疗:24 个月随访。
J Craniomaxillofac Surg. 2018 Jul;46(7):1153-1158. doi: 10.1016/j.jcms.2018.05.003. Epub 2018 May 9.

引用本文的文献

1
Treatment of Medication-Related Osteonecrosis of the Jaw Without and With the Use of Advanced Platelet-Rich Fibrin: A Retrospective Clinical Study.不使用和使用高级富血小板纤维蛋白治疗药物相关性颌骨坏死:一项回顾性临床研究
J Funct Biomater. 2025 May 14;16(5):180. doi: 10.3390/jfb16050180.
2
Differences Between Medication-Related Osteonecrosis of the Jaw Caused by Bisphosphonates and Denosumab: Histological, Molecular Biological, and Clinical Studies.双膦酸盐和地诺单抗所致颌骨药物性骨坏死的差异:组织学、分子生物学及临床研究
Cureus. 2024 Jun 21;16(6):e62855. doi: 10.7759/cureus.62855. eCollection 2024 Jun.
3
A case of successful treatment of medication-related osteonecrosis of the jaw with conservative treatment for pathological mandibular fracture.

本文引用的文献

1
Risk factors for developing medication-related osteonecrosis of the jaw when preserving the tooth that can be a source of infection in cancer patients receiving high-dose antiresorptive agents: a retrospective study.高剂量抗吸收剂治疗的癌症患者中,保留感染源牙齿时发生药物相关性颌骨坏死的风险因素:一项回顾性研究。
Support Care Cancer. 2022 Sep;30(9):7241-7248. doi: 10.1007/s00520-022-07134-y. Epub 2022 May 19.
2
American Association of Oral and Maxillofacial Surgeons' Position Paper on Medication-Related Osteonecrosis of the Jaws-2022 Update.美国口腔颌面外科学会关于药物相关性颌骨坏死的立场文件-2022 更新。
J Oral Maxillofac Surg. 2022 May;80(5):920-943. doi: 10.1016/j.joms.2022.02.008. Epub 2022 Feb 21.
3
1例药物相关性颌骨坏死合并病理性下颌骨骨折经保守治疗成功治愈的病例。
Int J Surg Case Rep. 2024 Jul;120:109822. doi: 10.1016/j.ijscr.2024.109822. Epub 2024 May 31.
4
Improvement of Quality of Life after Surgical Treatment of Patients with MRONJ: A Prospective Analysis Using the SF-12 and OHIP-14 Questionnaires.MRONJ患者手术治疗后生活质量的改善:使用SF - 12和OHIP - 14问卷的前瞻性分析
Int J Dent. 2024 Apr 30;2024:4435791. doi: 10.1155/2024/4435791. eCollection 2024.
5
Exploring the Impact of Novel Anti-Cancer Therapies on Jaw Osteonecrosis and Other Bones: A Comprehensive Review.探索新型抗癌疗法对颌骨坏死及其他骨骼的影响:一项综述
J Clin Med. 2024 Mar 25;13(7):1889. doi: 10.3390/jcm13071889.
6
Medication-related osteonecrosis of the lower jaw without osteolysis on computed tomography images.计算机断层扫描图像上无骨质溶解的下颌骨药物相关性骨坏死
J Bone Miner Metab. 2024 Jan;42(1):27-36. doi: 10.1007/s00774-023-01484-1. Epub 2024 Jan 9.
7
Comparing the Influence of Surgical and Conservative Therapy on Quality of Life in Patients with Early-Stage Medication-Related Osteonecrosis of the Jaw-A Prospective Longitudinal Study.比较手术和保守疗法对早期药物相关性颌骨骨坏死患者生活质量影响的前瞻性纵向研究。
Medicina (Kaunas). 2023 Jan 31;59(2):277. doi: 10.3390/medicina59020277.
8
Oral-Health-Related Quality of Life in Patients with Medication-Related Osteonecrosis of the Jaw: A Prospective Clinical Study.药物相关性颌骨坏死患者的口腔健康相关生活质量:一项前瞻性临床研究。
Int J Environ Res Public Health. 2022 Sep 16;19(18):11709. doi: 10.3390/ijerph191811709.
Relationship between tooth extraction and development of medication-related osteonecrosis of the jaw in cancer patients.
拔牙与癌症患者药物相关性颌骨坏死发展的关系。
Sci Rep. 2021 Aug 26;11(1):17226. doi: 10.1038/s41598-021-96480-8.
4
Periosteal reaction of medication-related osteonecrosis of the jaw (MRONJ): clinical significance and changes during conservative therapy.药物相关性颌骨骨髓炎(MRONJ)的骨膜反应:临床意义及保守治疗中的变化。
Support Care Cancer. 2021 Nov;29(11):6361-6368. doi: 10.1007/s00520-021-06214-9. Epub 2021 Apr 21.
5
Effect of periosteal reaction in medication-related osteonecrosis of the jaw on treatment outcome after surgery.药物相关性下颌骨坏死手术后骨膜反应对治疗效果的影响。
J Bone Miner Metab. 2021 Mar;39(2):302-310. doi: 10.1007/s00774-020-01154-6. Epub 2020 Oct 12.
6
Drug holiday clinical relevance verification for antiresorptive agents in medication-related osteonecrosis cases of the jaw.药物假期在治疗药物相关性颌骨骨坏死中的抗吸收药物的临床相关性验证。
J Bone Miner Metab. 2020 Jan;38(1):126-134. doi: 10.1007/s00774-019-01035-7. Epub 2019 Aug 13.
7
Medication-Related Osteonecrosis of the Jaw: MASCC/ISOO/ASCO Clinical Practice Guideline.药物相关性颌骨坏死:MASCC/ISOO/ASCO 临床实践指南。
J Clin Oncol. 2019 Sep 1;37(25):2270-2290. doi: 10.1200/JCO.19.01186. Epub 2019 Jul 22.
8
Clinical significance of periosteal reaction as a predictive factor for treatment outcome of medication-related osteonecrosis of the jaw.骨膜反应作为预测药物相关性颌骨骨坏死治疗效果的一个因素的临床意义。
J Bone Miner Metab. 2019 Sep;37(5):913-919. doi: 10.1007/s00774-019-00994-1. Epub 2019 Mar 4.
9
Conservative Surgical Treatment of Bisphosphonate-Related Osteonecrosis of the Jaw with Er,Cr:YSGG Laser and Platelet-Rich Plasma: A Longitudinal Study.钇钪石榴石激光联合富血小板血浆治疗双膦酸盐相关性颌骨骨坏死的保守性手术治疗:一项纵向研究。
Biomed Res Int. 2018 Aug 19;2018:3982540. doi: 10.1155/2018/3982540. eCollection 2018.
10
Can platelet-rich fibrin improve healing after surgical treatment of medication-related osteonecrosis of the jaw? A pilot study.富血小板纤维蛋白能否改善药物相关性颌骨骨坏死手术治疗后的愈合?一项初步研究。
Oral Surg Oral Med Oral Pathol Oral Radiol. 2018 Nov;126(5):390-403. doi: 10.1016/j.oooo.2018.06.007. Epub 2018 Jun 30.